Genentech filed a lawsuit against former employees accused of stealing trade secrets for developing and producing some of its top drugs, calling on a court to issue an injunction and award damages. More: Citing 'brazen' trade secrets theft, Genentech sues
read moreAstraZeneca CEO Pascal Soriot has repeatedly said his company would finally get back on the upswing in the second half of this year, and he’s put skeptics to rest with strong third-quarter numbers. Now, he’s doubling down on an even
read moreHikma has established itself as a top sterile injectables manufacturer in the U.S. and is building its business in Europe. Now the Mideast-based drugmaker is moving into Asia, picking up a production plant in Vietnam. More: Hikma to produce injectables
read moreUK-based Mallinckrodt has revealed that its experimental therapy for Niemann-Pick Type C failed to hit targets in a recently completed registration trial. More: Mallinckrodt’s Niemann-Pick Type C drug fails to hit trial target Source: News
read moreJazz Pharmaceuticals’ chemotherapy Vyxeos has won the backing of the National Institute for Health and Care Excellence (NICE) for routine use on the NHS in England and Wales to treat certain acute myeloid leukaemias (AML). More: NICE nod for Jazz’
read moreAstraZeneca’s product sales returned to growth in the third quarter, with new medicines and emerging markets driving performance. More: AZ books sales growth for the third quarter Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals